Navigation Links
A New Evaluation Tool That Could Predict Death Risk in Heart Patients

A new evaluation tool can predict the mortality risk in patients hospitalized with heart failure say researchers based on findings // of a recent study. According to researchers the new bedside tool is a first of its kind for the treatment of acute heart failure and offers a simple, quick way for clinicians to assess mortality risk upon hospital admission and quickly decide on a treatment strategy.

Researchers used data from more than 100,000 heart failure patients to develop a risk model after analyzing 33,046 hospitalizations. The overall mortality risk for patients hospitalized with acute heart failure was about 4 percent. The model determined mortality risk levels starting from low risk at about 2 percent up to nearly 22 percent for patients at the highest mortality risk.

Researchers evaluated 39 possible factors as survival indicators upon hospital admission. It was observed that the best single predictor for mortality was a high blood urea nitrogen level (above 43 milligrams per deciliter), followed by a low systolic blood pressure (above 115 millimeters of mercury) and a high serum creatinine (higher than 2.75 milligrams per deciliter).

Now that researchers have the ability to easily categorize patients by high and low mortality risk, they say that the new model may provide a more effective way to design clinical trials for evaluating heart failure therapies.
'"/>




Page: 1

Related medicine news :

1. Dietary supplementation of Folic Acid Requires Critical Evaluation
2. The Face Of Indian Health Care: A World Health Day Evaluation
3. Ohio Tobacco Research and Evaluation Center To Be Developed By Case
4. HIV Treatment Needs Re-Evaluation
5. Incorporate Sleep Evaluation into Routine Medical Care
6. Anti Inflammatory Evaluation Of Plumeria Acuminata Leaves
7. Patients Requests for Antidepressants can Influence Physician Evaluation of Depression
8. Lean Protein Could Be Key to Obesity Drugs
9. Nasal Spray Could Take Drugs Direct to Brain.
10. Nasal Spray Could Take Drugs Directly to Brain
11. Oxygen Usage During Exercise Could Indicate Heart Problems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... The Byron Eaton Agency, ... the central Alabama region, is organizing a local charity drive to send money and ... 11 trillion gallons of water have fallen on Houston as a result of Hurricane ...
(Date:9/25/2017)... WA (PRWEB) , ... September 25, 2017 , ... Introducing ... The project is live on crowdfunding platform Kickstarter seeking support for the ... 6 devices has fecal matter. All shockingly revolting, yet true. The Panther iPhone cases ...
(Date:9/25/2017)... ... September 25, 2017 , ... Winners in the ... on Friday, September 22 during a gala event in New York City. The ... and HR-related products and suppliers who help to create and drive great places ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... solutions for drugs, biologics and consumer health products, today announced that two of ... validation of bioassays at two upcoming conferences. , At the BEBPA 10th Annual ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... its Portable, Continuous, Miniature, and Modular (PCMM) collaboration with Pfizer and GEA by ... Solid Dosage line. The new PODs will provide tablet coating capability in the ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017 NuvoAir (formerly called Pond Healthcare ... a partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry ... the leading mobile spirometry platform and Novartis, commitment to address ... ... ...
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
(Date:9/6/2017)... 6, 2017 NeuroRx, a clinical stage biopharma company ... Behavior (ASIB), has been granted Fast Track status by the ... NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The ... of this sequential therapy targeting patients who are admitted to ... ...
Breaking Medicine Technology: